-transparent.png){kind=logo}
The in vitro activity of HR 756, 7-[2-(2-amino-4-thiazolyl)-2-(Z)-(methoximino)acetamido] cephalosporanic acid, was investigated against 659 isolates. HR 756 inhibited Neisseria and Haemophilus species at concentrations similar to those needed with ampicillin. It inhibited beta-lactamase-producing N. gonorrhoeae and H. influenzae. HR 756 was the most active compound tested against members of the Enterobacteriaceae, inhibiting most isolates of Escherichia coli, Klebsiella pneumoniae, Proteus mirabilis, Salmonella, Enterobacter, and Shigella at concentrations of less than 0.1 mug/ml. It was twice as active as carbenicillin against Pseudomonas aeruginosa and inhibited Bacteroides fragilis as well as cefoxitin. HR 756 killed E. coli, Staphylococcus aureus, and P. aeruginosa at rates similar to other beta-lactam antibiotics.
H C Neu, and
N Aswapokee, and
P Aswapokee, and
K P Fu
August 1983,
European journal of clinical microbiology,
H C Neu, and
N Aswapokee, and
P Aswapokee, and
K P Fu
December 1998,
Antimicrobial agents and chemotherapy,
H C Neu, and
N Aswapokee, and
P Aswapokee, and
K P Fu
March 1979,
Antimicrobial agents and chemotherapy,
H C Neu, and
N Aswapokee, and
P Aswapokee, and
K P Fu
December 1990,
The Journal of applied bacteriology,
H C Neu, and
N Aswapokee, and
P Aswapokee, and
K P Fu
August 1979,
Antimicrobial agents and chemotherapy,
H C Neu, and
N Aswapokee, and
P Aswapokee, and
K P Fu
December 1978,
Antimicrobial agents and chemotherapy,
H C Neu, and
N Aswapokee, and
P Aswapokee, and
K P Fu
November 2000,
The Journal of antibiotics,
H C Neu, and
N Aswapokee, and
P Aswapokee, and
K P Fu
January 1978,
Chemotherapy,
H C Neu, and
N Aswapokee, and
P Aswapokee, and
K P Fu
April 2022,
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America,
H C Neu, and
N Aswapokee, and
P Aswapokee, and
K P Fu
January 1979,
Giornale italiano di chemioterapia,
